Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
27,584,134
-
Shares change
-
+333,181
-
Total reported value, excl. options
-
$118,887,614
-
Value change
-
+$1,528,886
-
Number of buys
-
31
-
Number of sells
-
-40
-
Price
-
$4.31
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q1 2019
87 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q1 2019.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,584,134 shares
of 44,666,667 outstanding shares and own 62% of the company stock.
Largest 10 shareholders include First Light Asset Management, LLC (7,070,238 shares), BlackRock Inc. (2,978,196 shares), DIMENSIONAL FUND ADVISORS LP (2,047,730 shares), VANGUARD GROUP INC (1,836,648 shares), ROYCE & ASSOCIATES LP (1,730,200 shares), HEARTLAND ADVISORS INC (1,000,000 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (986,701 shares), ACADIAN ASSET MANAGEMENT LLC (770,735 shares), RENAISSANCE TECHNOLOGIES LLC (621,500 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (604,517 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.